Início › DPOC › Flórida

Ensaios clínicos de DPOC em Flórida

28 estudos para DPOC estão buscando participantes em locais em Flórida.

Cidades em Flórida

Texto oficial do estudo (Inglês)

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Meris Clinical Research- Site Number : 8400153, Brandon
Hillcrest Medical Research- Site Number : 8400082, DeLand
Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
e mais 18

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

International Clinical Research, Altamonte Springs
Nature Coast Clinical Research, Crystal River
Clinical Site Partners, LLC Leesburg dba Flourish Research, Leesburg
e mais 2

RecrutandoFase 2

Idades de 40 a 85 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07684820

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Millennium Medical Research - Miami, Miami
Deluxe Health Center, Miami Lakes
Florida Institute For Clinical Research, LLC, Orlando

RecrutandoFase 2

Idades de 40 a 75 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07759245

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

GSK Investigational Site, Miami
GSK Investigational Site, Tampa

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07780656

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
Finlay Medical Research- Site Number : 8400010, Miami

RecrutandoFase 4

Idades de 40 a 85 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07053423

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Helix Biomedics- Site Number : 8400065, Boynton Beach
Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
Eastern Medical Group Research- Site Number : 8400020, Fort Myers
e mais 10

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07190209

A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)

Helix Biomedics- Site Number : 8403065, Boynton Beach

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07793409

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Orlando Health, Orlando

Recrutando

Idades de 40 a 80 · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06035120

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

WB Contracted Clinical Research Site, Miami Lakes

RecrutandoFase 2

Idades de 40 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07646587

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Research Site, Brandon
Research Site, Cape Coral
Research Site, Clearwater
e mais 17

RecrutandoFase 2

Idades 40 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

GSK Investigational Site, Doral

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07780669

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

University of Florida, Jacksonville

RecrutandoFase 2

Idades 40 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Research Site, Bay Pines
Research Site, Boynton Beach
Research Site, Jacksonville
e mais 5

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Research Site, Clearwater
Research Site, Cutler Bay
Research Site, Cutler Bay
e mais 9

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Finlay Medical Research, Greenacres City
Clinical Research Specialists LLC, Kissimmee
Advanced Pulmonary Research Institute, Loxahatchee Groves
e mais 9

RecrutandoFase 2/3

Idades de 35 a 80 · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT07363694

Rademikibart IV for Acute Asthma and COPD Exacerbation

Columbus Clinical Services, LLC, Miami
Pharmax Research of South Florida, Inc., Miami

RecrutandoFase 2

Idades de 18 a 85 · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07705737

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Research Site, Boynton Beach
Research Site, Bradenton
Research Site, Cape Coral
e mais 25

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06283966

Alpha-1 Research Registry

Alpha-1 Foundation, Coral Gables

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT04157049

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

GC2501 Study Site 103, Gainesville
GC2501 Study Site 105, Miami

RecrutandoFase 3

Idades de 18 a 80 · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT07555483

STRIVE Post-Market Registry Study

University of Miami, Coral Gables

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

GSK Investigational Site, Brandon
GSK Investigational Site, Crystal River
GSK Investigational Site, Doral
e mais 8

RecrutandoFase 3

Idades de 40 a 75 · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

University of Miami, Miami

Recrutando

Idades de 18 a 100 · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT06578156

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

Mayo Clinic Jacksonville, Jacksonville

Recrutando

Idades de 40 a 80 · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT07051707

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Mayo Clinic, Jacksonville
Orlando Health, Orlando

Recrutando

Idades de 40 a 84 · Todos os sexos · Atualizado em 24 de abr. de 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

GSK Investigational Site, Brooksville
GSK Investigational Site, Doral
GSK Investigational Site, Fort Lauderdale
e mais 15

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 9 de abr. de 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

GSK Investigational Site, Loxahatchee Groves
GSK Investigational Site, Miami

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 8 de out. de 2025 · NCT06959095

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Hillcrest Medical Research, DeLand
Universal Axon Clinical Research, Doral
I.H.S Health, LLC, Kissimmee
e mais 3

RecrutandoEstudo observacional

Idades 50 e acima · Todos os sexos · Atualizado em 5 de ago. de 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

University of Florida, Jacksonville, Jacksonville
Alloy Clinical Research, Kissimmee
Reliable Research, Inc., Miami
e mais 2

Recrutando

Idades 30 e acima · Todos os sexos · Atualizado em 6 de fev. de 2025 · NCT05204888

Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.